Page 11 - Laboratory Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19 research Contact We’re involved in a broad range of activities with government and industry in response to COVID-19, including preclinical testing of potential vaccines, understanding the virus and its mutations, monitoring wastewater, supporting manufacturing of surgical masks, and analysing and sharing trends in data and the impact on health services. This is part of our efforts to future-proof Australia against the impacts of future pandemics, supporting national and global efforts to prevent, detect, respond to and recover from the threat of infectious diseas...

ANALYSIS: One year after, five gaps in Nigeria’s management of COVID-19 Nigeria recorded its first case of COVID-19 a year ago. 7 min read It is exactly 12 months since medics were summoned to what became the first confirmed case of COVID-19 in Nigeria. Since then, over 155,000 infections have led to more than 1,900 deaths. While Nigeria, like most African countries, has not suffered from the worst effect of the pandemic, unlike its European and American counterparts, the Nigerian government has made some blunders and faced some challenges in managing the virus. PREMIUM TIME...

Empowering Laboratory Professionals on Quality Management Systems during the Training of Trainers Format Port Louis - Thirty-two laboratory professionals responsible in the establishment and implementation of Quality Management System (QMS) have been trained during a five-day training workshop prior to the implementation of the Laboratory Quality Management System (LQMS) in Mauritius. The training of trainers aimed at building capacity of diagnostics laboratories and improve quality diagnostic service in the country. The training was conducted by the Ministry of Health and Wellness in close c...

For consideration of Rs 511 croreMetropolis Healthcare announced that the Board of Directors has approved the acquisition of Dr. Ganesan's Hitech Diagnostic Centre (Hitech). The acquisition will be a combination of cash and stock deal. The target entity is a debt free company. Cash consideration will be Rs. 511 crore and Metropolis will issue up to 4,95,000 equity shares of Face Value Rs.2/- each on preferential basis, subject to Shareholders approval, to the Promoter Group of Hitech. The Cash consideration will be funded through internal accruals and Debt of up to Rs. 300 crore. The acquisi...

Metropolis Healthcare announced that the board of directors has approved the acquisition of Dr. Ganesan's Hitech Diagnostic Centre (Hitech). Established in 1986, Hitech Diagnostic Centre is a diagnostics laboratory chain in the South India market. Metropolis will acquire 100% equity of Dr. Ganesan's Hitech Diagnostic Centre in a combination of cash and stock deal. The entity is a debt free company. This acquisition is expected to be completed within 3 months. Cash consideration will be Rs. 511 crore and Metropolis will issue up to 4,95,000 equity shares of Face Value Rs.2/- each on preferent...